Lexicon Pharmaceuticals
LXRX
#6755
Rank
A$0.95 B
Marketcap
A$2.26
Share price
1.24%
Change (1 day)
114.34%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): A-$0.30

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$0.26. In 2024 the company made an earnings per share (EPS) of A-$0.89 an increase over its 2023 EPS that were of A-$1.11.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.30-65.97%
2024A-$0.89-20%
2023A-$1.1131.15%
2022A-$0.85-0%
2021A-$0.8510.91%
2020A-$0.76-145.08%
2019A$1.69-206.09%
2018A-$1.60-5.74%
2017A-$1.69-10.95%
2016A-$1.902640%
2015A-$0.06937-96.34%
2014A-$1.89-2.53%
2013A-$1.94-9.09%
2012A-$2.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
A$24.65-9,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$7.60-2,984.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$59.82-22,794.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$8.10 2,973.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$8.74-3,415.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.69 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A-$1.04 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$2.52-1,057.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A-$106.42 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA